Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for VRTX
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- DavidK: $VRTX- Woodman - can’t recall if I reported back on the Journavx Pain Drug recently approved for Acute Pain only ( I received a 2 week supply ) . My back issues required something . This drug worked well for 7 days . I played in golf tournament and on a Sunday we had a 12 tee time . I took 1 pill around 11 and then another around 3 thinking this would help the swing along with many drinks . Anyway , I woke up that Monday all broken out in a rash which is a side effect . I stopped the drug . Today I had an epidural on spine and Dr told me I probably took those too close together along with the sun and booze . He claims his patients are raving about it . Issue it’s not approved for chronic pain yet
- woodman: @DavidK $VRTX - Wow. Back pain sucks. I've been there at times with debilitating back pain. Knock on wood, not in some time have I been put on the floor for days. How has the epidural gone for you? Will you ever try Jornavx again? Do you know if VRTX sought chronic pain relievf approval, or if it didn't why it didn't? I seem to recall that they may seek approval for chronic in the future, but I'm fuzzy on this.
- DavidK: @woodman $VRTX Dr didn’t know what their plans were for Acute Long term . I would love to take it when needed but my primary care doctor said be careful because if you have another allergic reaction it will be worse second time around . Epidural was my first . Dr said give it 2-3 days for it to kick in. My brother has back issues and all kind of procedures done and he said epidural should work for 3-4 months or longer . Then back to square 1 . I have 3 golf tournaments in June so I had to get it done . I am probably in better shape than 95% of 68 yr old men but whne that spine acts up it will bring you to your knees . Came out of no where about 3 months ago . Spinal stenosis with arthritis.
- woodman: @DavidK $VRTX - Good to hear that you should make it through your golf tournaments. I have multiple bulging discs that, at times, would really flare up. Not so much in recent years, but in my 20s and 30s, it was pretty bad at times. I was playing a lot of sports back then, which certainly didn't help. I had to give some of them up because of it. My back is often achy (which is tolerable), but no major blow outs in some time. Like you said, it puts you to your knees (and then on your back for several days).
- scottrades: Scott's video notes: $SPY Running up into resistance $QQQ Same $IWM Declining volume $GLD Sitting on the 8 EMA $GDX Support at the 21 EMA $IBIT Watch 54.60 $ETHA Watch 13.90 $NFLX Working but extended $NVDA Watch 111 $TSLA Watch the 200 Day $MSTR Earnings Thursday $PLTR Earnings Monday $HOOD Watch 51.10 $BOW Mentioned by Dan $RKLB Above all the MAs, Earnings May 8 $EW Watch 76.75 $VRTX Near the highs $JPM Near the 50 Day
- DavidK: $VRTX- went to chiropractor this morning fighting a bad back. Spinal stenosis and arthritis. Just came up out of nowhere a few months ago. Hard to play golf and had to back out of one tournament and have another coming next weekend. Bottom line I tol ...
- billyzeke: @DavidK $VRTX $SPY Yes keep us in the loop. I'd like to know how it works for you as I have been battling chronic back pain for years.
- Setshot: @DavidK $VRTX $SPY - Be careful with your back my friend. I started with back problems about 10 years ago. I suggest you see a neuro surgeon and get an MRI (Hope you are on Medicare so cost will be almost nothing). I played golf after my first surgery but that ended after two more lower back surgeries. Then I had neck surgery that has me on a walker and not sure I'll get off it (now almost 90). I do get back shots every 4 months and they help. I suggest you skip chiropracters and pain doctors and get at the real problem. Good luck.
- woodman: @DavidK $VRTX $SPY - Yeah, $VRTX's Journavx is their new non-opioid pain reliever for moderate or severe pain. like you said, acute, not chronic. I've been wondering how well it works. Non-opioid is a great thing. Please let us know how it works for you. Best of luck.
- Setshot: @DavidK $VRTX $SPY - I'm no doctor David but with all my other troubles, I sometimes get sudden pain in my back and hip area and other times it travels down my leg. I found the best solution was to visit a local clinic and get multi-day prednisone pills and they work like a charm in a few days.
- DavidK: @Setshot $VRTX $SPY yes I had a MRI done about a year ago and all my primary care doctor ( nurse who called me ) said was you’re getting old and spine shrinking . I said no shit . I had really no pain that wasn’t bearable. Anyway 4-5 wee ...
- Awesomeo: $VRTX could be a break out from a downward sloping trend line from the high in Dec and bounce off the 8dma
- bwcarnation1: $VRTX continues to work
- bwcarnation1: $VRTX it's green in a field of red
- X802tp01: $FIX - 29 $VRTX -13 $APP -9 $MSTR -14 $ALAB -11 $TSLA -24 $DUOL -20 $AXON -20 $NFLX -18 $CAVA -8 These are stocks from my watch list that are in the woodshed.
- woodman: $VRTX up nearly 30% off the bottom, continuing to do well a week after approval for its non-opioid pain killer.
- lance1161: @woodman $VRTX If this is truly what they say it is, after watching a family member who is so dependent and suffering from doctor prescribed benzo's, medicines like this should be a no brain(er) to avoid dependency at all costs. To the moon if this true once people grasp this... Even if they charge $15 a pill or so.....
- woodman: @lance1161 $VRTX - sorry to hear about your brother. I too hope this drug is all they say it is, and not some crazy Purdue/Sackler-type fraud.
- lance1161: @woodman $VRTX - Hmm. Never mentioned it was my brother. It is not, my concern is for those people now addicted and don't understand their plight to becoming normal functioning human beings. That stock should become a gold mine soon...
- woodman: @lance1161 $VRTX - sorry, I don't know where the heck I came up with your brother.
- woodman: $VRTX @lance1161 - looks like a lot of rivaling canidates in this TA, though a little behind. VRTX is the first approved. There are many Phase 1 and Phase 2 trials, and at least one Phase 3 trial, though VKTX's branding for "accute" pain may or may not separate it. I'm still investigating exactly what that may mean vs Chronic or OA or other types of pain focus.. https://x.com/Biomaven/status/1876296751042142716
- woodman: $VRTX - VRTX has an even bigger block-buster with its cystic fribrosis drug (Vanza triple aka Alyftrek), which is expected to be doing $8.3 billion in sales by 2030. The pain killer (Suztrigine) is expected to be doing a little less than $3 billion in sales by 2030.
- woodman: $VRTX - approval of its non-opioid pain killer. No risk of addiction. That seems like a big deal. https://www.cnbc.com/2025/01/30/fda-approves-vertex-non-opioid-painkiller-drug.html It also received approval of reimbursement for gene-edited therapy of sickle-cell disease from NHS of England.
- joelsg1: @woodman $VRTX Hurt my back tripping over packed go-bags in the zero-dark hours Tuesday and Advil/Tylenol not doing it for me so, yes a big deal if it works better without addictive properties.
- woodman: @joelsg1 $VRTX - Sorry to hear that. Get the 800 mg ibuprofen. I've thrown my back out a number of times. It's immobilizing. New non-opioid pain-killer treatment will be very welcome for chaps like us.
- joelsg1: @woodman $VRTX Thank you. I remain concerned about Advil because of the lawsuit by Seattle Seahawk cornerbacks years ago who suffered kidney damage when their trainers piled on the Advil for pain, though way above indicated dose. I tripped and fell face and teacup-first into a padded stairway, suffering some type of lower back compression issue, so far a slow recovery but I will step up dosage. Read that alternating Tylenol and Advil works since each drug works differently, so trying that as well.
- woodman: @joelsg1 $VRTX - Yes, there is some kindey risk. Talk to your doctor. I have to be easy on ibuprofen ever since removal of one of my kindeys (renal cancer). But the one I have remaining has done very well even though it's smaller and slightly less effective at its job than the one they removed. (They did cool scans to ensure my remaining kidney would be okay to do the job of two, before they removed the one that needed to go. I literally watched how they worked on a screen as they did their tests.) Before that, I used to use high dose ibuprofen for a short time when I threw my back out. Tylenol is inefective as pain relief for me. It does work differently, however. It metabolizes through the liver rather than the kidneys. So, don't drink on Tylenol!
- Henry: $VRTX live by the study die by the study
- dgrobo: Dan could you cover $JD and $VRTX in training
- DAN: @dgrobo $JD $VRTX JD pullback is pretty steep. This would need a lot more time to consolidate before it would be something to consider. VRTX -- I think I covered this today. If not, it's breaking out today on good volume. Seems a bit extended to be bought right here, but it's certainly one to be grabbing on a pullback. Hope this helps.
- dgrobo: Out of $VRTX. about $30 gain, got in after earnings and break above 50day
- dgrobo: Good morning all. My top 6 holdings, $MSTR (11%) $FBTC (10%) cash (7%) $NVDA (7%) ANET (6%) $VRT $VRTX $MSFT $DELL $RCL looking to trim the list but no clear laggards.
- RD: $VRTX Continues to run higher.
- RD: $VRTX VRTX reported earnings last night and now back above the 50dma. Looks interesting here with BB's expanding.
- camaro69: At or near ATH $VRTX, $V, $GD, $COST $ANET and $GE trying to BO
- woodman: $VRTX has been on fire. Among many other things, they have a non-addictive painkiller in the works. It reported on Phase 2 today. https://www.statnews.com/2023/12/13/vertex-non-opioid-drug-reduces-chronic-nerve-pain-in-mid-stage-study/?utm
- Margi1983: @woodman $CLRB Thanks for the update. Long with modest position. You really know your biotech stuff. These others are not really biotech but I am also long $VRTX, $LLY, $NVO, and $PFE in the pharma space
- woodman: @Margi1983 $CLRB $VRTX $LLY $NVO $PFE - I won't hold all my shares through, but I still need to decide how much I will hold through. It's risky for sure. I can't imagine the company would be promoting this data so much into the presentation(s), but crazy stuff happens in BioLand. It could be a disappointment even if "good" or just simply an immediate sell the news. One never knows.
- Margi1983: @Margi1983 $VRTX . Dang.. Up 8% today on news of a collaboration with Editas Medicine for gene editing tech. Missed the entry. Will wait for a pullback.
- Margi1983: $VRTX.Nice base since mid -November is now becoming a squeeze. Trying to break above the 50 ma. My guess is that @scottrades is watching this one
- bill52: $CRSP $VRTX Just my opinion but I think this is truly ground breaking and fascinating stuff for how diseases will be dealt with in the future. CRSP and VRTX partnered for the first ever approval of two therapies in the UK and expect approvals in the US in December. I'm not a doctor but sounds like you treat the problem at the DNA source and not just the symptoms. Here's one of the articles in IBD. https://finance.yahoo.com/m/4ce79342-7898-39b9-9cba-3697eeac8c6e/crispr-surges-after-winning.html
- DAN: @bill52 $CRSP $VRTX I agree with you, bill. CRISPR gene editing is really cutting edge and important stuff. It can do a lot of good.
- scottrades: Earnings AMC: $AMD $DVN $SBUX $PINS $MSTR $PXD $SEDG $ELF $LUMN $SPCE $CZR $VFC $PAYC $EXAS $VRTX $SU $MOS $CWH $MTCH $SHLW $TEX $CHK $TRIN $ULCC $EA $AIG $ALIT $BXP $AZPN $SFM $INSP $PRU $WTI $AFL $ALL $AXS $FLS $FRSH $DENN $COLM $BHR $OLO $PRTS $TX $VMEO $TCS $EHC $EXEL
- woodman: @scottrades $AMD $DVN $SBUX $PINS $MSTR $PXD $SEDG $ELF $LUMN $SPCE $CZR $VFC $PAYC $EXAS $VRTX $SU $MOS $CWH $MTCH $SHLW $TEX $CHK $TRIN $ULCC $EA $AIG $ALIT $BXP $AZPN $SFM $INSP $PRU $WTI $AFL $ALL $AXS $FLS $FRSH $DENN $COLM $BHR $OLO $PRTS $TX $VMEO $TCS $EHC $EXEL - Ugh, I hate earnings season.
- woodman: @sgiseller $CRSP - Thanks for the info. I can't believe I let $VRTX get away. I held it for a good while.
- woodman: $VRTX - I actually did well with it, selling and buying back at the right times, but with my last sale I failed to buy it back. Perfect W formation on the weekly. Now its going to the moon.
- joelsg1: @woodman $VRTX I had 1 right time, 1 wrong time, but lost track as well.
- woodman: $VRTX continues to move higher. Has been very strong.
- steve71: $MCRB Not for the fainthearted. I will be out before the close on Weds. Money good so far. $VRTX Biotechs go up and down. Vertex goes up. (There, I've jinxed it.) $XERS Their drug delivery platform is working. Now they just onboard more and more drugs.
- woodman: @steve71 $MCRB $VRTX $XERS - Nice work with $MCRB.I never got on board though looked at it a lot. $$ tied up elsewhere so I never really got in gear with it. I think your idea to sell before PDUFA is a good one. Seems that approval is very likely, but the stock still isn't moving as hard as one would hope/expect. I get a $CDTX vibe with it (though MCRB does have much greater institutional support than CDTX did/does). I also think there are some questions about rollout post-approval.
- steve71: @steve71 $MCRB $VRTX $XERS Guess I can only reply to myself, As an only child that's not a problem. I have also seen the JPM concern about slow early sales. That doesn't make sense to me. 20,000 C. diff deaths in U.S. yearly. C. diff is hard to treat initially. Recurrent C. diff is even more difficult, maybe because of drug resistance from the first round. So if recurrence can be 90% prevented why wouldn't the ICU doc treat every single initial case with SER-109? My bet is that every single primary case gets treatment - a run rate of 150,000 to 200,000 yearly in the U.S. alone. So I am hoping for post approval weakness for another bite of the apple.
- woodman: @steve71 $MCRB $VRTX $XERS - Makes sense. Often the post-approval dips turn out to be great opportunities. CDTX is still suffering from its post-approval migraine. (No position in CDTX currently.)
-
DAN: ...
$VRTX -- stopped at 299.
$ENPH -- stopped at 296.90
$TMDX -- Stop at 54.20. 50-day MA holding.
$VRNA -- Still going. Raising the stop to 21.95. Scott already suggested taking partial profits. This was a double at the open today, and you’re ... - sierramp: @woodman $ARDX $ETNB $PDSB $AMLX $ORMP $VKTX $DAWN $BMRN $CPRX $NWBO $SRPT $VRTX $XFOR #Biotech Thank you for this. Can't buy them using my usual process for evaluation but very, very interesting so attempting to come up with another way to evaluate. If you have time, would you share how they pass your test?
- woodman: $VRTX seemingly finding support at the 200d. Low risk area if nothing else.
- woodman: @sierramp $ARDX $ETNB $PDSB $AMLX $ORMP $VKTX $DAWN $BMRN $CPRX $NWBO $SRPT $VRTX $XFOR #Biotech - Catalysts (trial data due; FDA decisions due, etc.), important therapeutic areas and potential moats, interesting combos with established companies and institutions, strong interest by people I respect. Not all of these necessarily apply to each and every one, but some of these elements apply to each. Not an exhaustive list, but what instantly came to mind. Fwiw, I provided a small bit of color on most of these in a prior recent post here that you can search for. The chart is a factor, but to a more limited extent - less so than my ordinary trading MO.
- sierramp: @woodman $VRTX I'm in on that thesis.
- woodman: @sierramp $VRTX - I added fwiw.
- pperlroth: @woodman $ARDX $ETNB $PDSB $AMLX $ORMP $VKTX $DAWN $BMRN $CPRX $NWBO $SRPT $VRTX $XFOR #Biotech These are great! Thank you for sharing as I often look to this industry as the payouts can be massive given potential takeovers AND potential FDA approvals for new drugs/therapies.
- woodman: Updated list of #Biotech that I'm currently in ($$ amounts vary; not in any particular order): $ARDX $ETNB $PDSB $AMLX $ORMP $VKTX $DAWN $BMRN $CPRX $NWBO $SRPT $VRTX $XFOR (bought today).
- woodman: $VRTX - Smallish buy back for me. Seems to be firming up after the breakdown out of the channel. The 200d is still ~2% lower though. We'll see....
- scottrades: My notes: $SPY $QQQ Santa Rally? More like Santa Short Covering $GDX Going sideways $SLV Holding the 8EMA $XLE Choppy $XBI Tight $VRNA Consider more profits if you’re long $CPRX Don’t lose sight of this $VRTX Would like to see it tighten up $SRPT Working $CAH Holding the 8EMA $SHLS Still holding the 50 Day $ARRY Nice volume into the close $CROX Holding the 8EMA $G Tight weekly $Four High Handle $ELF Holding the 21 EMA $WPM Sold and bought some back $GOLD closed above the 8EMA
- woodman: Current #biotech and Big #Pharma that I'm in: $ARDX (gift drop 2 days ago; catalyst with news likely in January - see my prior posts) $CPRX (keeps going) $ORMP (strong today; catalyst into January for P3 results for oral insulin; also, CEO just talke ...
-
DAN: ...
$VRTX - A bit volatile lately, though the 50--day moving average is holding up well. Recall that it was Monday where I decided to lower the stop to below $300 because I felt the stop at 308.39 was just way too tight. When the stop is so tight that ... - jpoko13: @DAN $LLY $VRTX $CPRX $ENPH $TMDX $SHOP $VRNA $SQ My stop on $SHOP was $36.90 and was triggered last Thursday when the stock's low was $36.56.
- shoredriver: @jpoko13 $LLY $VRTX $CPRX $ENPH $TMDX $SHOP $VRNA $SQ ...or just sell the fat weeklies....that is a lot easier than door dash deliveries....
-
DAN: ...
$VRTX -- Strong rebound off the open and back above the 50d-ay MA. $305 should hold here. Stop remains below $300. Alert $299
$CPRX -- Nice breakout above $18. Working fine, but don’t be expecting too much. Alert $15.90
$ENPH -- Holding u ... -
DAN: ...
Regarding the active trade ideas, I'll point your attention to Vertex Pharma ($VRTX). The suggested max stop is currently set at 308.39. I have a problem with that because it is just slightly above the 50-day moving average at 307. So I am loweri ... -
Rockstar: ...
So what do we do now? I am going to be letting the short puts I sold either expire today or receive delivery of some of the underlying stocks. I am okay either way and will let the trades work. There has been some deterioration in the $XLE ETF an ... -
DAN: ...
$VRTX -- Holding the 20-day MA…stop at break even. As previously noted, I might have the stop too tight. But I’d rather just buy it back than stick with more of a pullback.
$CPRX -- Holding the trend. 20-day MA
$ENPH -- status quo
$T ... - traderbren: $VRTX - keep an eye on $VRTX this morning as it could move to a new high
-
DAN: ...
$VRTX - 308.90
$CPRX - 15.40
$ENPH - 296.90
$TMDX -- 54.20
$SHOP -- 37.00
$VRNA - 12.60
Have a great day.
--Dan - StockMarketMentor: A Price Alert has been triggered for $VRTX Vertex Pharmaceuticals Incorporated. Click here to view associated video clip: http://stockmarketmentor.com/stockanalysis.html?ticker=VRTX&clip=154523
-
DAN: ...
$VRTX - 308.90
$CPRX - 15.40
$ENPH - 296.90
$TMDX -- still at 54.20, but I don't like this action. With the stock still at a small paper loss, just watch it. Yesterday's low was 57.79. If the stock falls below that level, I would be selling. ... - Gpinewild: @Rockstar $DXY $VIX $XLF $XLI $XLB $XME $XLV $TAN $UNH $LOW $VRTX $FCX $CI $ON $NVDA $MSFT $SEDG $ENPH $GS $DIA $IWM $QQQ
-
DAN: ...
$VRTX -- Still holding the 20-day MA and in a very gradual uptrend. IT’s not blowing the doors off, but it’s “not not working” either. Our stop is at our entry point -- 308.39. Volume has been declining so I’m hopefu ... - Enrique: @DAN $REGN $SPY $QQQ $ASO $OLLI $SIG $MUSA $M $DBI $GME $CWH $CRM $TH $LLY $BTU $AMR $VRTX $CPRX $ENPH $TMDX $SHOP $VRNA Your website needs some TLC. Strategy session is blocking and can't be viewed
- Hemal: @DAN $REGN $SPY $QQQ $ASO $OLLI $SIG $MUSA $M $DBI $GME $CWH $CRM $TH $LLY $BTU $AMR $VRTX $CPRX $ENPH $TMDX $SHOP $VRNA Hey Dan, we are unable to access video for SS today 12/7/22
-
DAN: ...
$VRTX -- remains at 308.39
$CPRX - 15.40
$ENPH -- new stop at 296.90
$TMDX - 54.20
$SHOP - 37
$VRNA - 11.20
Have a great day.
--Dan -
DAN: ...
$VRTX -- Not acting well at all. Our stop is at our entry point -- 308.39. Volume has been declining so I’m hopeful that the selling is by weak hands and the trend will continue higher.
$CPRX -- Stop remains at 15.40. The trend is working ... -
Rockstar: ...
Many sectors continue to have a bullish outlook. The $XLF, $XLI,$XLB, $XME, $XLV, $TAN as well as a few other sectors, have developed into bullish charts and that is where I will focus for my longs. Some stocks that I am looking at are $UNH, $LOW, ... - DAN: Live Session at 8 am PT / 11 am ET Good morning. Today's training session begins at 8 am PT / 11 am ET. Stops on the active trade ideas are unchanged. I will be covering each of these stocks during the session: $LLY $BTU $AMR $VRTX $CPRX $ENPH $TMDX $SHOP $VRNA Here is the link to the training session: https://us02web.zoom.us/j/84851109626 Hope to see you there. --Dan
-
DAN: ...
$VRTX - 308.39
$CPRX - 15.40
$ENPH - 279.50
$TMDX - 54.20
$SHOP - 37.00
Have a good day.
--Dan - Nepenthe: @DAN $LLY $BTU $AMR $VRTX $CPRX $ENPH $TMDX $SHOP I don't see $VRNA on the ATL. Wasn't that added yesterday? Cheers.
- Kid2old: @Nepenthe $LLY $BTU $AMR $VRTX $CPRX $ENPH $TMDX $SHOP $VRNA Email at 7:55 am (PT) I did not see in Forum
- DAN: @Nepenthe $LLY $BTU $AMR $VRTX $CPRX $ENPH $TMDX $SHOP $VRNA My apologies. I can't find that post. What were the prices, Nepenthe? I'll put it on there. I have a small position in it, so I'm sure I mentioned it somewhere....just can't seem to find it.
- Kid2old: @DAN $LLY $BTU $AMR $VRTX $CPRX $ENPH $TMDX $SHOP $VRNA Active Trade Bulletin: Verona Pharma ($VRNA) Verona Pharma ($VRNA) is breaking out of a squeeze. I'm putting this on the Trade Ideas List: Basis: 13.47 Stop: 11.20 suggested maximum stop. --Dan
- marklpearson: @DAN $LLY $BTU $AMR $VRTX $CPRX $ENPH $TMDX $SHOP $VRNA email yesterday morning 9:55 am
- Nepenthe: @DAN $LLY $BTU $AMR $VRTX $CPRX $ENPH $TMDX $SHOP $VRNA What Kid2Old posted. No worries. You emailed it and then I believe the website had issues. Cheers.
- DAN: @Kid2old $LLY $BTU $AMR $VRTX $CPRX $ENPH $TMDX $SHOP $VRNA Thank you!!
- DAN: @Nepenthe $LLY $BTU $AMR $VRTX $CPRX $ENPH $TMDX $SHOP $VRNA Thanks! It's up now. 8-)
-
DAN: ...
$VRTX - 308.39 - 309.01 - 2022-11-08 - 308.39. Flat on this is the worst case scenario. I’m leaving this alone and letting it drift higher.
$CPRX - 17.00 - 16.32 - 2022-11-29 - 14.60 Raise to 15.40. Still walking along the 8 day ema.
$ENPH ... - scottrades: My notes: $SPY/$QQQ Digestion Day $DIA In trend $UUP At the 200-Day to the downside $GDX At the 200-Day to the upside $XME In trend $TAN Building a handle $SMH At the 200 Day. $IBB Working, see Dan’s ATL Trades $IGV Great volume #Bitcoin Still some Risk $BTU Trend is fine $ARLP Still needs time $FSLR Trend is fine $ENPH On Dan’s ATL $ARRY Whippy $RUN Holding the 8EMA $NVDA Working but still under the 200 Day $ON Wide price action $LSCC Working but also wide $AEHR Bought this today $SNOW Nice work on this in the forum $U Also watch this. $BA Clear resistance $MS Above all the MAs $CPRX Holding the 8EMA $VRTX Trending up along the 8EMA
-
DAN: ...
$VRTX. Basis 308.39. Stop at 308.39 This is a break even trade. However, this stop is pretty tight. The 50-day moving average is closer at 302, and the stock could conceivably pull back that far. Decide on your own risk parameters. Alert $324 ... -
DAN: ...
$VRTX -- $308.39
Have a good day, and a wonderful weekend.
--Dan -
DAN: Active Trade Bulletin: $LLY $BTU $VRTX $ACLX $AMR
$LLY - Up 8.61%. Leaving the stop at 349.40, which is about 4% below the current price. Due to the volatility in the market, I still want to give this stock some room. This trade idea has been op ... -
DAN: ...
$VRTX - 296.00
$ACLX -- 19.30
Have a good day.
--Dan -
DAN: ...
$VRTX -- Up about 3% from a 308.39 entry. Stop remains at 308.39 to take a risk of loss out of the equation.
$TWNK -- This was taken off the trade idea list prior to earnings. The stock has rebounded off the 20-day moving average and I took a ver ... - jpoko13: $VRTX itching for an add here...long
- woodman: @jpoko13 $VRTX - I'm still holding a decent position in this. It's a real patience-tester as the rising channel continues to narrow.
| Stock Price | $394.53 |
| Change | -0.71% |
| Volume | 978,280 |
Vertex Pharmaceuticals discovers, develops and commercializes small molecule drugs for the treatment of serious diseases.
Request Video of VRTXAlready a member? Sign in here.
Past Month
Leading Peers
-
$5.29 244.23%
-
$8.49 103.03%
-
$37.10 95.97%
Past Month
Lagging Peers
-
$24.81 -47.91%
-
$53.62 -37.49%
-
$10.03 -35.96%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!